Clinical trial
Noradrenergic Add-on Therapy With Guanfacine
NCT03116126
Study timeline
Study start (actual)2019-01-04Date precision: day
Registry last updated2024-05-13
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer Diseaseunresolved
Interventions
GuanfacineDRUG · verified · RxNorm: guanfacine
PlaceboDRUG
Sponsors & collaborators
Imperial College Londonlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03116126 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.